Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Global Calcium Pvt. Limited
483
•Global Calcium Pvt. Limited•February 3, 2026

Global Calcium Pvt. Limited – FDA 483, Feb 3, 2026

Record Details

Between January 27 and February 3, 2026, the FDA inspected Global Calcium Pvt. Limited, an active pharmaceutical ingredient manufacturer in Hosur, India. The inspection resulted in a Form 483 detailing six major areas of concern regarding the facility"s compliance with manufacturing standards. A primary issue involved significant data integrity failures in the microbiology laboratory, where staff recorded inaccurate microbial counts and lacked the training necessary to properly identify contaminated samples. Investigators also identified discrepancies between manual logs and biometric access records, indicating that required water samples were not actually collected at the times reported. Further violations included the use of unvalidated cleaning procedures that relied on undocumented, random volumes of cleaning agents, and laboratory equipment issues that compromised endotoxin testing. The firm’s Quality Unit was found to have failed in its oversight responsibilities, specifically by neglecting to perform a comprehensive retrospective review of past batches as previously committed. Additionally, the company"s internal reporting system for quality concerns was deemed inadequate because the reporting box was placed under a security camera, potentially discouraging employees from reporting issues. This document serves as a preliminary report of objectionable conditions. Global Calcium Pvt. Limited is required to respond to these observations by detailing their planned or implemented corrective actions. Failure to address these systemic documentation and quality control failures could lead to further regulatory enforcement, as the current findings suggest a lack of reliable data to ensure the safety and purity of the drug substances produced.

Company
Global Calcium Pvt. Limited
Inspection date
February 3, 2026
Product type
drugs
People
  • Alan A. Rivera
  • Jose E. Melendez (Quality System Specialist)
View Company Profile

ID · 125a8484-376d-4547-bbb5-b9c029bfe9ba

Violation Codes2
21 U.S.C. 374FD&C Act 704

Full citation text and observation details available on the Dashboard.

Other documents for Global Calcium Pvt. Limited
  • 483 - 2024-08-02August 2, 2024
  • WARNING_LETTER - 2024-08-02August 2, 2024
  • 483 - 2019-02-22February 22, 2019
  • 483 - 2015-04-06April 6, 2015
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Global Calcium Pvt. Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.